Tag: brain stimulation
Short-pulse DBS appears more effective than conventional DBS in tremor but...
In a systematic review and meta-analysis of the current literature, deep brain stimulation (DBS) with a short pulse width has been shown to potentially...
Vagus nerve stimulation demonstrates promise as non-medical treatment for narcolepsy
An initial evaluation of vagus nerve stimulation (VNS) in narcolepsy patients has linked this neuromodulation modality to a “significant improvement” in daytime sleepiness, leading...
Study reinforces ‘widely held but underexplored’ view that ECT is safe...
Researchers have found that electroconvulsive therapy (ECT)—whereby an electric current is passed through the brain of a patient under general anaesthesia to induce a...
Cognito announces 18-month data showing durability of gamma sensory stimulation for...
Cognito Therapeutics has announced that continued active treatment with the company’s gamma sensory stimulation technology in the Phase 2 OVERTURE open label extension (OLE)...
Expert roundtable devises roadmap on fatigue, mobility, brain stimulation and research...
The third Stroke Recovery and Rehabilitation Roundtable—an initiative of the International Stroke Recovery and Rehabilitation Alliance (ISRRA)—has made a series of key recommendations about...
Bilateral cerebellar rTMS represents “promising” treatment option for post-stroke dysphagia
Administering 10Hz cerebellar repetitive transcranial magnetic stimulation (rTMS) offers a “promising”, non-invasive treatment option in patients experiencing dysphagia following a subacute infratentorial stroke, as...
Biomarker-guided neuromodulation alleviates memory loss in traumatic brain injury patients
A collaborative study published in the journal Brain Stimulation has shown that targeted electrical stimulation in epilepsy patients with traumatic brain injury (TBI) can...
Flexible nanoelectrodes can “pave the way” for higher-resolution stimulation devices
Engineers at Rice University (Houston, USA) have created nanoelectrodes that are minimally invasive and exceptionally flexible—and, as such, have the potential to function as...
Highly targeted brain stimulation achieves “very exciting” outcomes in acute ischaemic...
Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
European Society for Brain Stimulation “strongly opposes” reclassification of non-invasive devices
The European Society for Brain Stimulation (ESBS) has said it “strongly opposes” the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation (NIBS)...
Feinstein Institutes reports on early vagus nerve mapping and details novel...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve...
Cognito announces first patient enrolment in US pivotal study of novel...
Cognito Therapeutics has announced the first patient enrolment in its US pivotal study, HOPE, which is designed to demonstrate the safety and efficacy of...
Transcutaneous auricular VNS proves effective in patients with mild cognitive impairment
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive...
Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...
NeuroOne receives US FDA 510(k) clearance to market Evo sEEG system...
NeuroOne Medical Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology...
HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial
In the randomised HD-RECOVERY clinical trial, the use of high-definition transcranial direct current stimulation (HD-tDCS) has been found to be associated with a statistically...
Self-administered tDCS reduces knee osteoarthritis pain in older adult patients
Home-based, self-administered transcranial direct current stimulation (tDCS) has demonstrated feasibility, acceptability and significant reductions in clinical pain intensity in older adults with knee osteoarthritis,...
Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients
In a randomised, sham-controlled clinical trial, multisession transcranial direct current stimulation (tDCS) paired with concurrent cognitive remediation training has been shown to promote social...
London clinic becomes first in UK to offer new drug-free Alzheimer’s...
The London Alzheimer’s Clinic on Harley Street (London, UK) has become the first clinic in the UK to offer transcranial pulse stimulation (TPS)—a “revolutionary”...
Multiple daily doses of iTBS provide no additional benefit in treatment-resistant...
In patients with treatment-resistant depression (TRD), multiple sessions of intermittent theta-burst stimulation (iTBS) do not accelerate responses to the therapy, nor do they improve...
Neuromod welcomes study demonstrating safety and efficacy of Lenire device in...
Neuromod Devices has welcomed the findings of an independent study performed at the German Hearing Center at Hannover Medical School (Hannover, Germany), which found...
Intermittent theta-burst stimulation found to be effective and well-tolerated in Alzheimer’s...
The findings of a randomised controlled trial (RCT) have indicated that accelerated intermittent theta-burst stimulation (iTBS), administered to the left dorsolateral prefrontal cortex (DLPFC), is an...
Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression
Stanford accelerated intelligent neuromodulation therapy (SAINT)—a novel, high-dose intermittent theta-burst stimulation (iTBS)—was found to be safe and more effective than sham stimulation in a...
Patient assent and lack of evidence among key ethical concerns identified...
A study intended to gain insight into prevailing ethical issues surrounding the use of deep brain stimulation (DBS) in adolescents with obsessive-compulsive disorder (OCD)...
Research shows brain rhythm changes occur ‘within minutes’ of DBS surgery...
New research published in Translational Psychiatry presents evidence that brief intraoperative exposure to therapeutic deep brain stimulation (DBS) at the time of implantation surgery induces...
Flow Neuroscience receives Series A funding to advance tDCS depression treatment
Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression,...
Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...
Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...
New algorithm could enable next-generation deep brain stimulation devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...
FDA approval of Axonics’ enhanced neurostimulator programmer
Axonics announces US Food and Drug Administration (FDA) approval of an enhanced, second-generation programmer for its r-SNM system under a premarket approval (PMA) application...
SPRINT peripheral nerve stimulation system demonstrates 12 months of low back...
SPR Therapeutics has announced publication of a prospective case series regarding its SPRINT peripheral nerve stimulation (PNS) system in the treatment of low back...
The Brainstorms Scientific set to host Europe’s first transdisciplinary neuroscience festival
The Brainstorms Scientific are launching the Brainstorms Festival, a two-day business and human-orientated technology event set to take place in Vienna, Austria, on 27–28...
